2022 The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years Group Lymphoma Working Party (LWP) 1st listed author Ali Bazarbachi Journal Leukemia.
2022 Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study Group Inborn Errors Working Party (IEWP) 1st listed author Michael H Albert Journal Blood.
2022 Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study Group Chronic Malignancies Working Party (CMWP) Transplant Complications Working Party (TCWP) 1st listed author Anna Waszczuk-Gajda Journal J Clin Med.
2022 Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Edouard Forcade Journal Bone Marrow Transplant.
2022 Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019 Group Chronic Malignancies Working Party (CMWP) 1st listed author Dawn Swan Journal Br J Haematol.
2022 Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Cancer Med.
2022 Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) Other society 1st listed author Annalisa Ruggeri Journal Transplant Cell Ther.
2022 Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Clin Cancer Res.
2022 Human leukocyte antigen-haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia-free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal Am J Hematol.
2022 Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Ivetta Danylesko Journal Bone Marrow Transplant.
2022 Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) 1st listed author Rama Al Hamed Journal Cancer Med.
2022 Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.